Semax is a synthetic heptapeptide derived from the ACTH(4–10) sequence and designed without the hormonal activity associated with full-length adrenocorticotropic hormone (ACTH). It has been studied for its interactions with neurological and neurotrophic signaling pathways.
Preclinical and human research has examined Semax in relation to neurotrophic factor signaling, neuronal activity, gene expression, and mechanisms associated with neural plasticity. Experimental studies have also investigated its interactions with signaling processes involved in central nervous system function and cellular responses.
These characteristics make Semax a compound of interest for investigating neurotrophic signaling, neuronal biology, neural plasticity, and related central nervous system pathways under controlled research conditions.
Semax is supplied exclusively for laboratory research and analytical purposes. Not for human or animal consumption. Not intended for diagnostic, therapeutic, or clinical use.
